News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Sara Ling, RN, PhD

Ms Ling is an Advanced Practice Clinical Leader at CAMH, and a PhD candidate in the Bloomberg School of Nursing at the University of Toronto.

Articles by Sara Ling, RN, PhD

opioid crisis

Harnessing Harm-Reduction Methods to Combat the Opioid Crisis

ByNazanin Izadi, HBSc,Anees Bahji, MD, FRCPC,Nitin Chopra, MD,Sara Ling, RN, PhD,Helena B. Hansen, MD, PhD,Tony P. George, MD, FRCPC

September 14th 2021

Lessons from Novel Harm Reduction Methods

ByNazanin Izadi, HBSc,Anees Bahji, MD, FRCPC,Nitin Chopra, MD,Sara Ling, RN, PhD,Helena B. Hansen, MD, PhD,Tony P. George, MD, FRCPC

June 1st 2021

How can understanding the opioid crisis in Canada inform strategies in the United States?

Latest Updated Articles

Harnessing Harm-Reduction Methods to Combat the Opioid Crisis
September 14th 2021
Lessons from Novel Harm Reduction Methods
June 1st 2021

Trending on Psychiatric Times

Positive Topline Results From Phase 3 Emerge Study of DT120 ODT in Major Depressive Disorder

FDA Issues CRL for Cytisinicline for Smoking Cessation in Adults

Evaluating Transdermal Asenapine in Schizophrenia

Empowering Patients and Expanding Formulation Options in Schizophrenia Care